PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
4 hedge funds and large institutions have $686K invested in PureTech Health in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
136% more capital invested
Capital invested by funds: $290K → $686K (+$395K)
33% more funds holding
Funds holding: 3 → 4 (+1)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| 1 |
AIC
AWM Investment Company
New York
|
+$176K |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$173K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
1
Pentwater Capital Management
Naples,
Florida
| $485K | +$173K | +6,756 | +66% |
|
|
AIC
2
AWM Investment Company
New York
| $197K | +$176K | +6,900 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3.92K | +$2.4K | +94 | +219% |
|
4
UBS Group
Zurich,
Switzerland
| $570 | – | – | – |
|
PRTC Hedge Fund Activity: Q1 2024 in Review
4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q1 2024, worth a combined $686K — up 136% from $290K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PRTC positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $176K.
- 4 institutional investors held PureTech Health (PRTC) as of Q1 2024, up from 3 in Q4 2023.
- Funds reported $686K of PureTech Health stock for Q1 2024, up 136% quarter-over-quarter.
- 1 fund opened new PureTech Health positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest PureTech Health buyer in Q1 2024 was AWM Investment Company, an estimated $176K added.
Based on aggregated 13F filings for Q1 2024.